EP0268640A4 - Vaccin stimulant ou ameliorant la production d'anticorps contre le gm2. - Google Patents

Vaccin stimulant ou ameliorant la production d'anticorps contre le gm2.

Info

Publication number
EP0268640A4
EP0268640A4 EP19870903575 EP87903575A EP0268640A4 EP 0268640 A4 EP0268640 A4 EP 0268640A4 EP 19870903575 EP19870903575 EP 19870903575 EP 87903575 A EP87903575 A EP 87903575A EP 0268640 A4 EP0268640 A4 EP 0268640A4
Authority
EP
European Patent Office
Prior art keywords
improving
production
antibodies against
vaccine
stimulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19870903575
Other languages
German (de)
English (en)
Other versions
EP0268640A1 (fr
Inventor
Philip O Livingston
Lloyd J Old
Michele Jones Calves
Edward J Natoli
Herbert F Oettgen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Memorial Sloan Kettering Cancer Center
Original Assignee
Memorial Sloan Kettering Cancer Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Memorial Sloan Kettering Cancer Center filed Critical Memorial Sloan Kettering Cancer Center
Publication of EP0268640A1 publication Critical patent/EP0268640A1/fr
Publication of EP0268640A4 publication Critical patent/EP0268640A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • A61K39/001169Tumor associated carbohydrates
    • A61K39/001171Gangliosides, e.g. GM2, GD2 or GD3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588Adjuvants of undefined constitution
    • A61K2039/55594Adjuvants of undefined constitution from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP19870903575 1986-05-07 1987-05-07 Vaccin stimulant ou ameliorant la production d'anticorps contre le gm2. Withdrawn EP0268640A4 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US86066386A 1986-05-07 1986-05-07
US860663 1986-05-07
US4480187A 1987-04-30 1987-04-30
US44801 1987-04-30

Publications (2)

Publication Number Publication Date
EP0268640A1 EP0268640A1 (fr) 1988-06-01
EP0268640A4 true EP0268640A4 (fr) 1989-11-30

Family

ID=26722007

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19870903575 Withdrawn EP0268640A4 (fr) 1986-05-07 1987-05-07 Vaccin stimulant ou ameliorant la production d'anticorps contre le gm2.

Country Status (4)

Country Link
EP (1) EP0268640A4 (fr)
JP (1) JPH01500119A (fr)
AU (1) AU603585B2 (fr)
WO (1) WO1987006840A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1334984A1 (fr) * 1989-05-25 2003-08-13 Sloan-Kettering Institute For Cancer Research Anticorps anti-idiotypiques induisant une réaction immunitaire contre un glycosphingolipide, et son utilisation
US6432402B1 (en) 1989-05-25 2002-08-13 Sloan-Kettering Institute For Cancer Research Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
US6805862B1 (en) 1989-05-25 2004-10-19 Sloan-Kattering Institute For Cancer Research Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
US7585512B1 (en) 1990-05-08 2009-09-08 Thomas Jefferson University Composition and method of using tumor cells
US6149921A (en) * 1993-12-29 2000-11-21 Centro De Inmunologia Molecular Vaccine compositions for eliciting an immune response against N-acetylated gangliosides and their use for cancer treatment
CU22420A1 (es) * 1993-12-29 1996-01-31 Centro Inmunologia Molecular Composicion vacunal para el desarrollo de una respuesta contra gangliosidos n glicolilados y su uso para el tratamiento del cancer
ES2302337T3 (es) * 1995-06-07 2008-07-01 Thomas Jefferson University Extracto de celulas tumorales modificadas con hapteno y procedimientos para tratar cancer.
US5792455A (en) * 1996-03-21 1998-08-11 Sloan-Kettering Institute For Cancer Research Anti-idiotypic antibody vaccines
CA2346061A1 (fr) * 1998-10-01 2000-04-06 Progenics Pharmaceuticals, Inc. Vaccins aux hydrates de carbone contre les maladies virales
FR2790960B1 (fr) * 1999-03-15 2002-10-31 Pf Medicament Utilisation de fractions membranaires bacteriennes a activite immunostimulante dans le traitement de cancers, leurs procedes de preparation et les compositions pharmaceutiques les contenant

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3135663A (en) * 1960-06-28 1964-06-02 Glaxo Group Ltd Vaccines
US3567585A (en) * 1963-07-12 1971-03-02 Ciba Geigy Corp Process for obtaining bcg-cultures
US4557931A (en) * 1982-12-02 1985-12-10 Regents Of The University Of California Antigenic compositions and methods for using same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents have been disclosed. *

Also Published As

Publication number Publication date
AU7435887A (en) 1987-12-01
EP0268640A1 (fr) 1988-06-01
WO1987006840A1 (fr) 1987-11-19
AU603585B2 (en) 1990-11-22
JPH01500119A (ja) 1989-01-19

Similar Documents

Publication Publication Date Title
NO872966D0 (no) Fremgangsmaate for fremstilling av granulocyttstimulerende preparater.
NO875082D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridinoksimer.
FI872379A7 (fi) Menetelmä farmakologisesti vaikuttavien 1,5-diaryyli-3-(w-substituoitu-alempi-alkyyli)-pyratsolien valmistamiseksi
NO871277D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive oxadiazoler.
IT8722220A0 (it) Metodo per la preparazione di titanio silicaliti.
DE3777253D1 (de) Herzschrittmacher zur stimulierung des menschlichen herzens.
FI871750A7 (fi) Lääkeaineiden nenänsisäinen antaminen.
NO874869D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO870240D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno-1,4-diazepiner.
DE3883651D1 (de) Herzschlagabhängiger Schrittmacher.
EP0283505A4 (fr) Vaccin et procede de preparation.
FI885399A7 (fi) Uusi lääkevoide, menetelmä sen valmistamiseksi, tätä lääkevoidetta käy ttämällä aikaansaadut käyttömuodot sekä niiden valmistus
DE3778585D1 (de) Herzschrittmacher zur stimulierung des menschlichen herzens.
EP0268640A4 (fr) Vaccin stimulant ou ameliorant la production d'anticorps contre le gm2.
DE3789316D1 (de) Herstellung von human-parathyroidhormon.
DE3778587D1 (de) Herzschrittmacher zur stimulierung des menschlichen herzens.
FI875684A7 (fi) 1,1,2,2-tetrahydroperfluorialkanolien ja niiden estereiden valmistusmenetelmä.
IT1225474B (it) Procedimento per la preparazione di compresse solubili e/o divisibili e compresse cosi' ottenute.
NO881768L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner.
FR2617502B1 (fr) Preparation enzymatique d'anhydro-1,5 d fructose
IT8767940A0 (it) Procedimento microbiologico per lapreparazione di 9 alfa -idrossi4-androstene-3,17 dione
IT1217352B (it) Palizzata in calcestruzzo nonche'procedimento e dispositivo per laproduzione della stessa.
NO862390D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater.
NO166280C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n,n'-disubstituerte ureaer.
FI875685A7 (fi) 1,1,2,2-tetrahydroperfluorialkanolien ja niiden estereiden valmistusmenetelmä.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17P Request for examination filed

Effective date: 19880510

A4 Supplementary search report drawn up and despatched

Effective date: 19891130

17Q First examination report despatched

Effective date: 19910730

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19920211

RIN1 Information on inventor provided before grant (corrected)

Inventor name: OLD, LLOYD, J.

Inventor name: CALVES, MICHELE, JONES

Inventor name: NATOLI, EDWARD, J.

Inventor name: LIVINGSTON, PHILIP, O.

Inventor name: OETTGEN, HERBERT, F.